Design Therapeutics Inc (DSGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,795 | -36,798 | -17,715 | -49,588 | -35,937 |
| Depreciation Amortization | -2,275 | -1,663 | -901 | -5,602 | -4,313 |
| Other Working Capital | 2,150 | -714 | -1,708 | -993 | -2,605 |
| Other Operating Activity | 11,528 | 7,945 | 3,535 | 13,078 | 9,610 |
| Operating Cash Flow | $-42,392 | $-31,230 | $-16,789 | $-43,105 | $-33,245 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 34,655 | 28,145 | 7,942 | 44,295 | 42,463 |
| PPE Investments | -159 | -159 | -72 | -340 | -340 |
| Investing Cash Flow | $34,496 | $27,986 | $7,870 | $43,955 | $42,123 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 421 | 384 | 23 | 513 | 250 |
| Financing Cash Flow | $421 | $384 | $23 | $513 | $250 |
| Beginning Cash Position | 22,563 | 22,563 | 22,563 | 21,200 | 21,200 |
| End Cash Position | 15,088 | 19,703 | 13,667 | 22,563 | 30,328 |
| Net Cash Flow | $-7,475 | $-2,860 | $-8,896 | $1,363 | $9,128 |
| Free Cash Flow | |||||
| Operating Cash Flow | -42,392 | -31,230 | -16,789 | -43,105 | -33,245 |
| Capital Expenditure | -159 | -159 | -72 | -340 | -340 |
| Free Cash Flow | -42,551 | -31,389 | -16,861 | -43,445 | -33,585 |